Labor laws are critical to ensuring fairness for workers, and they have an impact on the economy as they can impact output and employment trends. So our hugely-experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts in this sector (Get a free issue of The Kiplinger Letter or subscribe). You will get all the latest news first by subscribing, but we will publish many of the forecasts a few days afterward online. Here’s the latest…
California labor regulators are seeking the nation’s toughest lead regulations. Under the proposed rules, the allowable amount of workplace airborne lead would decline by 80%, and workers would be more quickly reassigned to jobs with less lead exposure upon reaching a certain threshold. Employees who work with lead would also face more stringent blood-lead-level testing requirements.
Officials cite new research on the harms of lead exposure, which finds that blood lead levels as low as 5 micrograms per deciliter have been associated with impaired kidney and reproductive function, high blood pressure and more.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The rules on the books now are designed to keep employee BLLs below 40 mpd and California regulators want to lower that threshold to less than 10 mpd.
Federal labor regulators are also working on new lead exposure rules. The Occupational Safety and Health Administration currently requires medical removal for workers with 60 micrograms of lead per deciliter in general industry, 50 mpd in construction. It’s unclear how low the feds will set their new standard.
This forecast first appeared in The Kiplinger Letter, which has been running since 1923 and is a collection of concise weekly forecasts on business and economic trends, as well as what to expect from Washington, to help you understand what’s coming up to make the most of your investments and your money. Subscribe to the Kiplinger Letter here.
-
Here's Why Walmart Deals are Better Than Amazon Prime DayWith sales for Walmart Deals and Amazon Prime Day running comparable on price, one factor separates them.
-
How to Get Rid of the Things Your Kids Don't Want While DownsizingWhether moving by necessity or choice, downsizing means deciding what to do with your stuff. Here's what to do if the kids and grandkids don't want it all.
-
AI’s Rapid Rise Sparks New Cyber ThreatsThe Kiplinger Letter Cybersecurity professionals are racing to ward off AI threats while also using AI tools to shore up defenses.
-
Blue Collar Workers Add AI to Their ToolboxesThe Kiplinger Letter AI can’t fix a leak or install lighting, but more and more tradespeople are adopting artificial intelligence for back-office work and other tasks.
-
America's Surprising Strengths in Manufacturing and ExportsThe Kiplinger Letter Despite common perceptions that the U.S. doesn't build things anymore, American factories are still hard at work. A special report from The Kiplinger Letter.
-
Will State Laws Hurt AI’s Future?The Kiplinger Letter Republicans in Congress are considering a moratorium on state AI laws. But it’s likely a growing patchwork of state AI regulations will be here for a while.
-
The New AI Agents Will Tackle Your To-Do ListThe Kiplinger Letter Autonomous AI agents “see” your computer screen, then complete a task, from buying a concert ticket to organizing email. This opens up a world of possibilities.
-
AI’s Medical RevolutionThe Kiplinger Letter Medicine is a field ripe for finding both exciting and practical uses for AI. The tech is already being used by doctors and researchers.
-
The Economic Impact of the US-China Trade WarThe Letter The US-China trade war will impact US consumers and business. The decoupling process could be messy.
-
AI Heads to WashingtonThe Kiplinger Letter There’s big opportunity for AI tools that analyze MRIs and other medical images. But also big challenges that clinicians and companies will have to overcome.
